Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +1 vs. Q1 2024
- Shares held
- 16.3M
- −952.1K (−5.5%) vs. Q1 2024
- Total value
- $56.3M
- −$34.5M (−38.0%) vs. Q1 2024
- New holders
- 7
- 7 more added
- Sold out
- 6
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 3 | $10 | 0.00% | −34,903−100.0% | Reduced |
| JPMorgan Chase & Co | 16 | $56 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $101 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 80 | $278 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 81 | $289 | 0.00% | 00.0% | Unchanged |
| SJS Investment Consulting Inc. | 100 | $348 | 0.00% | +100 | New |
| Bank of America Corp | 238 | $829 | 0.00% | −9,891−97.7% | Reduced |
| Qube Research & Technologies Ltd | 492 | $1.71K | 0.00% | +492 | New |
| BFSG, LLC | 1,000 | $3.48K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,081 | $4.00K | 0.00% | +1,081 | New |
| CWM, LLC | 2,416 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,484 | $8.64K | 0.00% | −960−27.9% | Reduced |
| FMR LLC | 4,146 | $14.4K | 0.00% | +4,146 | New |
| Morgan Stanley | 5,866 | $20.4K | 0.00% | −15,593−72.7% | Reduced |
| Advisor Group Holdings, Inc. | 11,026 | $38.4K | 0.00% | −634−5.4% | Reduced |
| Squarepoint Ops LLC | 11,395 | $39.7K | 0.00% | +11,395 | New |
| Virtu Financial LLC | 15,488 | $54.0K | 0.00% | +15,488 | New |
| Simplex Trading, LLC | 17,107 | $59.0K | 0.00% | +17,107 | New |
| Barclays PLC | 19,261 | $67.0K | 0.00% | −3,816−16.5% | Reduced |
| UBS Group AG | 19,266 | $67.0K | 0.00% | +14,530+306.8% | Added |
| Charles Schwab Investment Management Inc | 23,302 | $81.1K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 30,315 | $105.5K | 0.00% | +9,984+49.1% | Added |
| Northern Trust Corp | 49,962 | $173.9K | 0.00% | −56−0.1% | Reduced |
| AdvisorShares Investments LLC | 51,780 | $184.9K | 0.03% | −20,291−28.2% | Reduced |
| Renaissance Technologies LLC | 64,900 | $225.9K | 0.00% | −44,900−40.9% | Reduced |
| Susquehanna International Group, LLP | 65,107 | $226.6K | 0.00% | −223,778−77.5% | Reduced |
| Two Sigma Investments, LP | 67,511 | $234.9K | 0.00% | −76,875−53.2% | Reduced |
| Blair William & Co | 88,466 | $307.9K | 0.00% | +20,000+29.2% | Added |
| State Street Corp | 88,708 | $308.7K | 0.00% | +5,000+6.0% | Added |
| BML Capital Management, LLC | 150,000 | $522.0K | 0.38% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 174,982 | $608.9K | 0.00% | +8,818+5.3% | Added |
| Geode Capital Management, LLC | 290,094 | $1.01M | 0.00% | +10,612+3.8% | Added |
| Armistice Capital, LLC | 300,000 | $1.04M | 0.03% | −64,000−17.6% | Reduced |
| BlackRock Inc. | 402,747 | $1.40M | 0.00% | +54,309+15.6% | Added |
| Citadel Advisors LLC | 629,645 | $2.19M | 0.00% | −114,275−15.4% | Reduced |
| Sphera Funds Management Ltd. | 808,550 | $2.81M | 0.46% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,517,696 | $5.28M | 0.53% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,529,338 | $5.32M | 1.02% | −329,397−17.7% | Reduced |
| Commodore Capital LP | 1,575,000 | $5.48M | 0.37% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,848,582 | $5.85M | 1.72% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,793,166 | $6.24M | 0.00% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $6.96M | 0.20% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,676,580 | $9.31M | 0.97% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −89,938−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,498−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −32,291−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,443−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −8,441−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −211−100.0% | Sold out |